In February 2015 Oxford Global’s 10th Annual Biomarkers Congress gave delegates the opportunity to present a poster and have the chance of winning an award of £3,000.

The award was decided by a panel of five judges made up from some of the esteemed congress speakers presenting across the two days.

Mari Enoksson, of Novo Nordisk won the award by presenting: Biomarker discovery study for detection of a haemophilic joint bleed. Mari decided to donate the £3,000 award prize to a charity of our choice. Oxford Global continually supports the work of Cancer Research UK and therefore we made the £3,000 donation to the charity. We would like to thank Mari for allowing Oxford Global to make this donation.

Cancer Research UK’s vision is to bring forward the day when all cancers are cured. In the 1970s, less than a quarter of people with cancer survived. But over the last 40 years, survival has doubled – today half will survive. Their ambition is to accelerate progress and see three-quarters of people surviving the disease within the next 20 years.